Abiopharma

Clinical trial NCT06726148: intervention model: SINGLE_GROUP → PARALLEL.

Clinical trial NCT06551584: primary completion date: 2026-05-01 → 2026-12-01.

Clinical trial NCT07595549 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-30 → 2026-06-10

Clinical trial NCT07590193 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-15 → 2026-06-11

Clinical trial NCT06702592: start date: 2026-05-01 → 2026-07-01.

Clinical trial NCT06427876 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04522544: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT03016338 updates: 1. status: UNKNOWN → ACTIVE_NOT_RECRUITING 2. completion date: 2025-12-01 → 2026-12-01

Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Companys Proprietary DIFS™ Platform

Clinical trial NCT03836209: completion date: 2026-12-01 → 2026-07-01.